CD | UC | BD | Control | P value | |
---|---|---|---|---|---|
Number of patients | 39 | 51 | 17 | 16 | |
Gender | |||||
Male | 20 | 27 | 9 | 14 | 0.070 |
Female | 19 | 24 | 8 | 2 | |
Mean age (±SD), yr | 32.4 ± 14.5 | 45.2 ± 22.8 | 47.5 ± 17.6 | 32.4 ± 3.8 | 0.014 |
BMI (±SD), kg/m2 | 19.0 ± 3.6 | 21.6 ± 3.7 | 20.4 ± 3.8 | 0.006 | |
CDAI | |||||
≥ 150 | 12 | ||||
< 150 | 27 | ||||
CAI | |||||
≥ 6 | 29 | ||||
< 6 | 22 | ||||
Disease location | |||||
CD | |||||
Ileal type | 9 | ||||
Ileocolonic type | 25 | ||||
Colonic type | 4 | ||||
Unknown | 1 | ||||
UC | |||||
Pancolitis | 41 | ||||
Left side colon | 4 | ||||
Rectum | 5 | ||||
Unknown | 1 | ||||
Current treatment | |||||
5-ASA | 25 | 43 | 13 | ||
Steroid | 2 | 18 | 6 | ||
Azathioprine | 0 | 5 | 0 | ||
Infliximab | 5 | 0 | 0 | ||
Adalimumab | 1 | 0 | 0 | ||
GMA/LCAP | 1 | 6 | 1 | ||
AIM (μg/ml) | |||||
Average (±SD) | 3.3 ± 2.1 | 1.9 ± 1.4 | 2.3 ± 1.4 | 2.1 ± 0.6 | <0.001 |
WBC (±SD), x102/μl | 6.7 ± 2.6 | 8.4 ± 3.9 | 7.3 ± 2.8 | – | 0.055 |
CRP (±SD), mg/dl | 2.5 ± 3.5 | 3.6 ± 5.8 | 2.7 ± 4.0 | – | 0.929 |
IgM (±SD), mg/dl | 141.5 ± 124.3 | 118.0 ± 77.9 | 118.0 ± 64.9 | – | 0.275 |